Niagen Bioscience, Inc. Financial Ratios
NAGE|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
22.7%
Profit Margin
13.4%
Net Income / Revenue
Asset Turnover
1.22
Revenue / Total Assets
Equity Multiplier
1.39
Total Assets / Equity
Composite: 22.7% (reported: 22.7%)
Profitability
Liquidity
Current Ratio
4.86
Quick Ratio
4.86
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
1.22
Inventory Turnover
-
Days Sales Outstanding
27 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+4.4%
+22.1pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.